The list recognizes both the scientific achievements of individual scientists and “their profound impact on tackling broader societal challenges.”

The study findings point to the potential of interleukin-13 antibodies — approved for use in humans — as a treatment to protect against bacterial pneumonia in patients with zinc deficiency.

Crowe and his colleagues have developed cutting-edge technologies to isolate and study antiviral antibodies.

The discovery, reported in the journal PLOS Pathogens, could help open the door to the development of effective vaccines and antibody therapies with an “exceptional breadth of pathogen coverage.”

The mechanistic understanding of how cells respond to heat could explain how chronic inflammation contributes to the development of cancer.

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

Science Immunology study suggests a new class of inborn errors of immunometabolism and could improve care for patients with these complex diseases.